Official Journal of The Kidney Cancer Association
Volume 16, Number 2 2018
kidney-cancer-journal.com
An Edu cational Service for Medical Oncologists, Hematologist-Oncologists, and Urologists
Now in Its 16th Year
Checkpoint Inhibitors:
Guidelines to Limit
Immune-Related Adverse
Effects
Controversies and
Consensus on Initial
Cytoreductive
Nephrectomy vs Targeted
Therapy
ASCO 2018: What's the
Impact on Your Practice?
/kidney-cancer-journal.com